• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.12% Nasdaq Up 0.71%

    PDL BioPharma, Inc. (PDLI)

    -NasdaqGS
    7.02 Down 0.09(1.27%) Apr 24, 4:00PM EDT
    |After Hours : 7.02 0.00 (0.00%) Apr 24, 7:09PM EDT
    Add to Portfolio
    Prev Close:7.11
    Open:7.10
    Bid:6.98 x 3300
    Ask:7.30 x 4000
    1y Target Est:7.50
    Beta:0.62
    Next Earnings Date: 6-May-15PDLI Earnings announcement
    Day's Range:6.98 - 7.10
    52wk Range:6.52 - 10.26
    Volume:4,104,261
    Avg Vol (3m):3,786,030
    Market Cap:1.15B
    P/E (ttm):3.77
    EPS (ttm):1.86
    Div & Yield:0.60 (8.60%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for PDLI

    Comparison

    Symbol% ChgMkt Cap
    PDLIDown 1.27%1.15B
    AMGNDown 0.74%127.61B
    SGENDown 0.96%4.63B
    XOMADown 0.55%420.98M

    Key Statistics

    Forward P/E (1 yr):8.89
    P/S (ttm):2.37
    Ex-Dividend Date:02-Dec-15

    Analysts

    Annual EPS Est (Dec-15) :2.20
    Quarterly EPS Est (Mar-15) :0.52
    Mean Recommendation*:3.0
    PEG Ratio (5 yr expected):0.23

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    PDL BioPharma, Inc. manages a portfolio of patents and royalty assets in the United States and Europe. The company is involved in the humanization of monoclonal antibodies and the discovery of a new generation of targeted treatments for cancer and... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback